Supriya Lifescience - Quaterly Results

10 Nov 2022 Evaluate
Net sales declined -24.14%  to  Rs. 1121.72 million from Rs. 1478.58 millions.The Company to register a -71.04%  fall in the net profit for the quarter ended September 2022.A decline of 541.47 millions was observed in the OP in the quarter ended September 2022 from 971.04 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1121.72 1478.58 -24.14 2135.27 2248.00 -5.01 5300.49 3912.45 35.48
Other Income 26.05 33.21 -21.56 49.62 52.60 -5.67 75.77 49.77 52.24
PBIDT 541.47 971.04 -44.24 877.50 1144.96 -23.36 2215.62 1781.51 24.37
Interest 237.55 168.87 40.67 243.36 178.61 36.25 41.98 40.80 2.89
PBDT 303.92 802.17 -62.11 634.14 966.35 -34.38 2173.64 1740.71 24.87
Depreciation 29.73 24.63 20.71 58.58 49.40 18.58 101.18 67.61 49.65
PBT 274.19 777.54 -64.74 575.56 916.95 -37.23 2072.46 1673.10 23.87
TAX 105.57 195.33 -45.95 154.44 257.35 -39.99 554.35 437.16 26.81
Deferred Tax 0.91 -1.90 -147.89 3.91 44.07 -91.13 32.46 6.94 367.72
PAT 168.62 582.21 -71.04 421.12 659.60 -36.16 1518.11 1235.94 22.83
Equity 160.97 146.37 9.97 160.97 146.37 9.97 160.97 146.37 9.97
PBIDTM(%) 48.27 65.67 -26.50 41.10 50.93 -19.31 41.80 45.53 -8.20

Supriya Lifescience Share Price

745.85 0.95 (0.13%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×